You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 156 No. 8, 22 APRIL 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL OBSERVATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Clinical Spectrum of Jin Bu Huan Toxicity

Rivka S. Horowitz, MD, PhD; Kim Feldhaus, MD; Richard C. Dart, MD, PhD; Frank R. Stermitz, PhD; John J. Beck

Arch Intern Med. 1996;156(8):899-903.


Abstract

Herbal medications and other nontraditional medical therapies are becoming increasingly popular in the United States. We describe three children and three adults in whom severe toxic effects developed after ingestion of a Chinese herbal medication, jin bu huan, which is sold as Jin Bu Huan Anodyne Tablets. Jin bu huan produced distinct clinical syndromes after acute ingestion in children and long-term use in adults. A single, acute ingestion in children rapidly produced life-threatening neurologic and cardiovascular manifestations, while long-term jin bu huan use in adults was associated with hepatitis. Jin bu huan contains levo-tetrahydropalmatine, a potent neuroactive substance. The constituents of jin bu huan are misidentified on the package, resulting in significant delay in identifying the plant alkaloid responsible for its toxicity. Although perceived as innocuous, jin bu huan may produce major health effects. The highly concentrated formulation, the lack of childproof packaging, and the product insert listing indications for the treatment of serious medical conditions may all contribute to the development of toxic reactions.

(Arch Intern Med. 1996;156:899-903)



Author Affiliations

From the Rocky Mountain Poison Center, Denver, Colo (Drs Horowitz and Dart); the Department of Emergency Medicine, Denver General Hospital (Dr Feldhaus); and the Department of Chemistry and Agricultural Experiment Station, Colorado State University, Fort Collins (Dr Stermitz and Mr Beck).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Drug-Induced Liver Disease and Drug Use Considerations in Liver Disease
Kim and Phongsamran
Journal of Pharmacy Practice 2009;22:278-289.
ABSTRACT  

Herbal Remedies and Children: Do They Work? Are They Harmful?
Woolf
Pediatrics 2003;112:240-246.
ABSTRACT | FULL TEXT  

Tetrahydropalmatine Poisoning: Diagnoses of Nine Adult Overdoses Based on Toxicology Screens by HPLC with Diode-Array Detection and Gas Chromatography–Mass Spectrometry
Lai and Chan
Clin. Chem. 1999;45:229-236.
ABSTRACT | FULL TEXT  

Herbal and Related Remedies
Bartels and Miller
Nutr Clin Pract 1998;13:5-19.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.